NTNU – Norwegian University of Science and Technology

NTNU Colourlab

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

6,451 to 6,460 of 6,740 Results

qmigrant_questionnaire_no.txt Jun 16, 2020 - Replication Data for: Diskriminering og sosial ekskludering av skeive med innvandrerbakgrunn Plain Text - 114.2 KB - MD5: 260428f8f2b1cff4b0edef8e15df40dc QMigrant question and response set, Norwegian version
qmigrant_questionnaire_pl.txt Jun 16, 2020 - Replication Data for: Diskriminering og sosial ekskludering av skeive med innvandrerbakgrunn Plain Text - 128.1 KB - MD5: b8b7e4438eb386c2cda792ea386cf601 QMigrant question and response set, Polish version
qmigrant_response_mapping.txt Jun 16, 2020 - Replication Data for: Diskriminering og sosial ekskludering av skeive med innvandrerbakgrunn Plain Text - 17.6 KB - MD5: e19858f44bf42d9db4a90cbf7d5442b7 Response de-identifying mapping, English response names
qmigrant_responses.txt Jun 16, 2020 - Replication Data for: Diskriminering og sosial ekskludering av skeive med innvandrerbakgrunn Plain Text - 349.8 KB - MD5: e1a894fbe46b7828b86e9da877164cfb Response data set
01_3_NINA-1_SPIRIT2013_33_item_checklist.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 100.2 KB - MD5: 5225602d1b3fdff2f18a9189a37b8db6 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT 2013) This statement provides evidence for the minimum content of the NINA-1 trial protocol as outlined by SPIRIT
02_NINA-1_IB_version_7_March2020.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 1.1 MB - MD5: b7b54792d295074da50ddc8a6c820739 INVESTIGATOR’S BROCHURE PRODUCT: Nalokson DnE Nasal Spray 14 mg/mL
05_3_NINA-1_Financing_Contract_NTNU_FarmaIndusriAS.pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 971.7 KB - MD5: 3448326f647098679153a61679819f99 Agreements between NTNU and Farma Industri governing the funding of Study Medicine and ensuring NTNU full ownership of trial results.
05_3_NINA-1_Financing_Regional_Health_Authority(EN_NO).pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 3.3 MB - MD5: a95cf2d72d1dfc324e125ab8dcba0430 Financing for PhD position for Arne Skulberg supervised by Prof. Ola Dale and main funding for NINA-1
06_1_NINA-1_National_Ethics_Approval_March_2017_(EN_NO).pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 7.8 MB - MD5: ea3a92eae5a70cf98e2cfe42711db753 Trial approval and review by The National Committee for Medical and Health Research Ethics (NEM) in Norway
06_1_NINA-1_Regional_Ethics_Approval_March_2020(EN_NO).pdf Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents Adobe PDF - 1.0 MB - MD5: b30e40d8eb4857663520f6a8324ea060 Approval of protocol version 3.3 06. March 2020 by The Regional Committee for Medical and Health Research Ethics (REC) in Norway

qmigrant_questionnaire_no.txt

Jun 16, 2020 - Replication Data for: Diskriminering og sosial ekskludering av skeive med innvandrerbakgrunn

Plain Text - 114.2 KB -

QMigrant question and response set, Norwegian version

qmigrant_questionnaire_pl.txt

Jun 16, 2020 - Replication Data for: Diskriminering og sosial ekskludering av skeive med innvandrerbakgrunn

Plain Text - 128.1 KB -

QMigrant question and response set, Polish version

qmigrant_response_mapping.txt

Jun 16, 2020 - Replication Data for: Diskriminering og sosial ekskludering av skeive med innvandrerbakgrunn

Plain Text - 17.6 KB -

Response de-identifying mapping, English response names

qmigrant_responses.txt

Jun 16, 2020 - Replication Data for: Diskriminering og sosial ekskludering av skeive med innvandrerbakgrunn

Plain Text - 349.8 KB -

Response data set

01_3_NINA-1_SPIRIT2013_33_item_checklist.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 100.2 KB -

Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT 2013) This statement provides evidence for the minimum content of the NINA-1 trial protocol as outlined by SPIRIT

02_NINA-1_IB_version_7_March2020.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 1.1 MB -

INVESTIGATOR’S BROCHURE PRODUCT: Nalokson DnE Nasal Spray 14 mg/mL

05_3_NINA-1_Financing_Contract_NTNU_FarmaIndusriAS.pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 971.7 KB -

Agreements between NTNU and Farma Industri governing the funding of Study Medicine and ensuring NTNU full ownership of trial results.

05_3_NINA-1_Financing_Regional_Health_Authority(EN_NO).pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 3.3 MB -

Financing for PhD position for Arne Skulberg supervised by Prof. Ola Dale and main funding for NINA-1

06_1_NINA-1_National_Ethics_Approval_March_2017_(EN_NO).pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 7.8 MB -

Trial approval and review by The National Committee for Medical and Health Research Ethics (NEM) in Norway

06_1_NINA-1_Regional_Ethics_Approval_March_2020(EN_NO).pdf

Apr 23, 2020 - NTNU Intranasal Naloxone Trial (NINA-1) Study documents

Adobe PDF - 1.0 MB -

Approval of protocol version 3.3 06. March 2020 by The Regional Committee for Medical and Health Research Ethics (REC) in Norway

Add Data

Share Dataverse

Link Dataverse

Reset Modifications